2 results  1 of 1 

1 Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
Vandana Midha, Ramit Mahajan, Varun Mehta, Vikram Narang, Arshdeep Singh, Kirandeep Kaur, Ajit Sood
Intest Res.2018;16(1):83-89.   Published online 2018 January 18     DOI: http://dx.doi.org/10.5217/ir.2018.16.1.83
      
2 Recalcitrant Cutaneous Ulcer of Comorbid Patient Treated with Platelet Rich Plasma: A Case Report
Dai Hyun Kim, Jong Yeob Kim, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye, Jae Eun Choi
J Korean Med Sci.2012;27(12):1604-1606.   Published online 2012 December 7     DOI: http://dx.doi.org/10.3346/jkms.2012.27.12.1604
      

 1 of 1